BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 12824270)

  • 1. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
    Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
    Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
    Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
    Kumazaki K; Nakayama M; Suehara N; Wada Y
    Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated gene transfer of placental growth factor to perivascular tissue induces angiogenesis via upregulation of the expression of endogenous vascular endothelial growth factor-A.
    Roy H; Bhardwaj S; Babu M; Jauhiainen S; Herzig KH; Bellu AR; Haisma HJ; Carmeliet P; Alitalo K; Ylä-Herttuala S
    Hum Gene Ther; 2005 Dec; 16(12):1422-8. PubMed ID: 16390273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ocular neovascularization by co-inhibition of VEGF-A and PLGF.
    Huo X; Li Y; Jiang Y; Sun X; Gu L; Guo W; Sun D
    Cell Physiol Biochem; 2015; 35(5):1787-96. PubMed ID: 25832861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
    Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
    Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR).
    Regnault TR; Orbus RJ; de Vrijer B; Davidsen ML; Galan HL; Wilkening RB; Anthony RV
    Placenta; 2002; 23(2-3):132-44. PubMed ID: 11945079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical nepafenac inhibits ocular neovascularization.
    Takahashi K; Saishin Y; Saishin Y; Mori K; Ando A; Yamamoto S; Oshima Y; Nambu H; Melia MB; Bingaman DP; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):409-15. PubMed ID: 12506103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
    Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
    Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.
    Carmeliet P; Moons L; Luttun A; Vincenti V; Compernolle V; De Mol M; Wu Y; Bono F; Devy L; Beck H; Scholz D; Acker T; DiPalma T; Dewerchin M; Noel A; Stalmans I; Barra A; Blacher S; VandenDriessche T; Ponten A; Eriksson U; Plate KH; Foidart JM; Schaper W; Charnock-Jones DS; Hicklin DJ; Herbert JM; Collen D; Persico MG
    Nat Med; 2001 May; 7(5):575-83. PubMed ID: 11329059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression.
    Feeney SA; Simpson DA; Gardiner TA; Boyle C; Jamison P; Stitt AW
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):839-47. PubMed ID: 12556420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-mediated expression of vascular endothelial growth factor induces choroidal neovascularization in rat.
    Wang F; Rendahl KG; Manning WC; Quiroz D; Coyne M; Miller SS
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):781-90. PubMed ID: 12556414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system.
    Hara C; Kasai A; Gomi F; Satooka T; Sakimoto S; Nakai K; Yoshioka Y; Yamamuro A; Maeda S; Nishida K
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4321-9. PubMed ID: 23722395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.
    Ohno-Matsui K; Yoshida T; Uetama T; Mochizuki M; Morita I
    Biochem Biophys Res Commun; 2003 Apr; 303(3):962-7. PubMed ID: 12670505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.
    Autiero M; Waltenberger J; Communi D; Kranz A; Moons L; Lambrechts D; Kroll J; Plaisance S; De Mol M; Bono F; Kliche S; Fellbrich G; Ballmer-Hofer K; Maglione D; Mayr-Beyrle U; Dewerchin M; Dombrowski S; Stanimirovic D; Van Hummelen P; Dehio C; Hicklin DJ; Persico G; Herbert JM; Communi D; Shibuya M; Collen D; Conway EM; Carmeliet P
    Nat Med; 2003 Jul; 9(7):936-43. PubMed ID: 12796773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
    Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
    Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of TNP-470 on experimental choroidal neovascularization in a rat model.
    Ishida K; Yoshimura N; Mandai M; Honda Y
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1512-9. PubMed ID: 10359334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.